Sutter Health — San Francisco, California

Public research footprint of Sutter Health, compiled from the ClinicalTrials.gov public registry.

145

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Parkinson's Disease and Parkinsonism · PDAC - Pancreatic Ductal Adenocarcinoma · Aortic Valve Insufficiency · Residual, Progressive or Recurrent Grade II or III Meningioma

Recently updated registry entries

NCT06678841 — ELEVATE-HFpEF Clinical Study (Recruiting)
NCT05627362 — A Study to Assess Safety and Effectiveness of Elafibranor in Adult Participants With… (Active Not Recruiting)
NCT06667076 — A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Sutter Health?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.